摘要
本文以恒瑞医药作为研究对象,通过收集、整理和分析其专利申请数据,重点关注抗肿瘤药物这一领域,从激酶抑制剂、偶联物领域和其他抗肿瘤领域入手,分析其专利技术的特点和现状,总结专利技术的发展脉络与布局情况,以期为后续企业申请人在研发方向、专利布局等方面提供参考。
This article takes Hengrui Medicine as the research object, collects, sorts and analyzes its patent application data, focusing on the field of anti-tumor drugs, starting from the field of kinase inhibitors, conjugates and other anti-tumor fields, and analyzing its patented technology. This paper analyzes its characteristics and current situation, summarizes the development of its patent technology and layout, and hopes to provide reference for the research and development direction and patent layout of other applicants.
作者
齐洁
刘明
于秀培
Qi Jie;Liu Ming;Yu Xiu pei(Patent Examination Cooperation Jiangsu Center of the Patent Office,CNIPA,Suzhou 215163,China)
出处
《广东化工》
CAS
2019年第4期122-123,共2页
Guangdong Chemical Industry
关键词
恒瑞
医药
专利
抗肿瘤
hengrui
medicine
patent
anti-tumor